Please Note: This trial is no longer enrolling new participants
A Randomized Phase II/III Study of Docetaxel and Ramucirumab with or without Cemiplimab (REGN2810) for Participants Previously Treated with Platinum-based Chemotherapy and Immunotherapy for Stage IV or Recurrent Non-Small Cell Lung Cancer (Lung-MAP Non-Matched Sub-Study)
| Protocol No. | CTO-S1800E | Scope | National |
|---|---|---|---|
| Principal Investigator | Rohan Maniar | Treatment Type | Treatment |
| Age Group | Adult | Phase | Phase II/III |
